We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05261269
Brief Title: A Dose-escalation Study of the Safety and Pharmacology of DAN-222 in Subjects With Metastatic Breast Cancer

First Submitted : February 15, 2022
First Submitted that Met QC Criteria : February 25, 2022
First Posted : March 2, 2022

Last Update Submitted that Met QC Criteria : January 17, 2023
Last Update Posted : January 18, 2023